Metropolis Healthcare Ltd
Metropolis Healthcare Ltd (METROPOLIS) last traded at ₹567, a market capitalisation of ₹11,760 crore, on a P/E of 56.5. Over the past 52 weeks the stock has ranged between ₹412 and ₹609. Metropolis Healthcare Ltd last reported results for the quarter ended Jun 2026, with sales of ₹450 crore and net profit of ₹57 crore. The next scheduled event is an analyst meet on 27 Aug 2026. Figures are as of 25 Aug 2026 and are not real time.
Metropolis Healthcare Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Metropolis Healthcare Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹450 cr, up 16.6% from ₹386 cr a year earlier. Net profit was ₹57 cr, up 26.7% year on year.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 350 | 323 | 345 | 386 | 429 | 406 | 425 | 450 |
| Expenses | 260 | 251 | 283 | 296 | 321 | 311 | 317 | 339 |
| Operating profit | 90 | 72 | 62 | 90 | 108 | 95 | 108 | 111 |
| OPM % | 26% | 22% | 18% | 23% | 25% | 23% | 25% | 25% |
| Other income | 3 | 3 | 7 | 8 | 1 | -0 | 8 | 5 |
| Interest | 5 | 5 | 5 | 5 | 6 | 6 | 8 | 6 |
| Depreciation | 27 | 28 | 29 | 31 | 32 | 32 | 39 | 32 |
| Profit before tax | 61 | 42 | 36 | 61 | 71 | 57 | 70 | 78 |
| Tax % | 24% | 26% | 19% | 26% | 26% | 26% | 27% | 27% |
| Net profit | 47 | 31 | 29 | 45 | 53 | 42 | 51 | 57 |
| EPS (₹) | 2.27 | 1.53 | 1.41 | 2.17 | 2.54 | 2.00 | 2.46 | 2.73 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Metropolis Healthcare Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 998 | 1,228 | 1,148 | 1,208 | 1,331 | 1,646 | 1,710 |
| Operating profit | 290 | 348 | 293 | 288 | 308 | 406 | 422 |
| OPM % | 29% | 28% | 26% | 24% | 23% | 25% | 25% |
| Net profit | 183 | 215 | 143 | 128 | 146 | 191 | 203 |
| EPS (₹) | 8.95 | 10.46 | 6.98 | 6.24 | 7.00 | 9.17 | 9.73 |
TTM is the trailing twelve months to the most recent quarter.
Metropolis Healthcare Ltd growth and returns
- 10 Years
- 13%
- 5 Years
- 11%
- 3 Years
- 13%
- TTM
- 22%
- 10 Years
- 11%
- 5 Years
- 1%
- 3 Years
- 11%
- TTM
- 37%
- 10 Years
- %
- 5 Years
- -3%
- 3 Years
- 19%
- 1 Year
- 3%
- 10 Years
- 19%
- 5 Years
- 15%
- 3 Years
- 12%
- Last Year
- 14%
Metropolis Healthcare Ltd shareholding pattern
Promoters held 48.86% at Jun 2026, broadly unchanged since Jun 2025. FIIs 11.03% and DIIs 35.12%.
| % held | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Promoters | 49.43% | 49.40% | 48.89% | 48.89% | 48.89% | 48.87% | 48.86% | 48.86% |
| FIIs | 18.56% | 16.73% | 15.29% | 12.83% | 12.52% | 11.68% | 10.43% | 11.03% |
| DIIs | 28.02% | 30.00% | 30.30% | 32.40% | 33.10% | 34.73% | 35.80% | 35.12% |
| Public | 3.98% | 3.86% | 5.51% | 5.87% | 5.48% | 4.69% | 4.92% | 5.00% |
| No. of shareholders | 51,852 | 48,572 | 49,293 | 50,015 | 47,846 | 46,670 | 49,175 | 50,636 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Upcoming Metropolis Healthcare Ltd events
The next scheduled event is an analyst meet on 27 Aug 2026.
- Analyst meetLarge format Investors & Analyst Meet
See the full results calendar for every Indian company reporting in the next 30 days.
Metropolis Healthcare Ltd corporate filings
- Disclosure under Regulation 30 of SEBI Listing RegulationsCompany Updatelow impact
Cruxal's analysis: Metropolis Healthcare has submitted a disclosure under Regulation 30 of the SEBI (Listing…
Read the full analysis - Schedule of Analyst / Institutional Investor MeetingCompany Updatelow impact
Cruxal's analysis: Metropolis Healthcare has announced a scheduled meeting with analysts and institutional…
Read the full analysis - Scrutinizer''s Report for the 26th Annual General MeetingAGM/EGMlow impact
Cruxal's analysis: Metropolis Healthcare Limited has released the Scrutinizer's Report for its 26th Annual…
Read the full analysis - Proceedings of the 26th Annual General Meeting of the CompanyAGM/EGMlow impact
Cruxal's analysis: Metropolis Healthcare Limited has successfully concluded its 26th Annual General Meeting…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Metz Advisory LLP & PACsInsider Trading / SASTmedium impact
Cruxal's analysis: Metz Advisory LLP, part of the promoter group of Metropolis Healthcare Limited, has…
Read the full analysis - The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Duru Shah Family Trust & PACsInsider Trading / SASTmedium impact
Cruxal's analysis: Metropolis Healthcare Limited has disclosed that the Duru Shah Family Trust, a member of…
Read the full analysis - Transcript of Q1 FY27 earnings conference call held on Wednesday, August 05, 2026Company Updatehigh impact
Cruxal's analysis: Metropolis Healthcare Limited reported a strong Q1 FY27 performance with revenue of INR…
Read the full analysis - Link of audio recording of the earnings conference call held on August 05, 2026Company Updatelow impact
Cruxal's analysis: Metropolis Healthcare Limited has formally filed the audio recording of its earnings…
Read the full analysis - Newspaper PublicationCompany Updatelow impact
Cruxal's analysis: Metropolis Healthcare Ltd has fulfilled its regulatory obligation under Regulation 30 of…
Read the full analysis - Investor Presentation for the quarter ended June 30, 2026Company Updatehigh impact
Cruxal's analysis: Metropolis Healthcare Limited reported a strong Q1 FY27 performance with revenue from…
Read the full analysis - Press ReleaseCompany Updatelow impact
Cruxal's analysis: Metropolis Healthcare has filed a press release under Regulation 30 of the SEBI (LODR)…
Read the full analysis - Unaudited Standalone and Consolidated Financial Results for the quarter ended June 30, 2026Resulthigh impact
Cruxal's analysis: Metropolis Healthcare reported consolidated revenue from operations of 450.22 crore for…
Read the full analysis - Grant of Stock BenefitsCompany Updatelow impact
Cruxal's analysis: Metropolis Healthcare Ltd. has disclosed the grant of stock benefits, a routine corporate…
Read the full analysis - Allotment of 18,700 equity shares under the Metropolis-Restrictive Stock Unit Plan, 2020Company Updatemedium impact
Cruxal's analysis: Metropolis Healthcare Ltd. announced the allotment of 18,700 fully paid-up equity shares…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Metropolis Healthcare Ltd
Cruxal reads every Metropolis Healthcare Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.